Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hudson memorial lecture: Wilson's disease: genetics and biochemistry--their relevance to therapy.

× No keyword cloud information.

29 in total

1. Wilson's disease and the concentration of caeruloplasmin in serum.

Authors: I H SCHEINBERG; I STERNLIEB
Journal: Lancet Date: 1963-06-29 Impact factor: 79.321

2. Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease.

Authors: G E CARTWRIGHT; H MARKOWITZ; G S SHIELDS; M M WINTROBE
Journal: Am J Med Date: 1960-04 Impact factor: 4.965

3. Penicillamine, a new oral therapy for Wilson's disease.

Authors: J M WALSHE
Journal: Am J Med Date: 1956-10 Impact factor: 4.965

Review 4. Copper homeostasis in the mammalian system.

Authors: G W Evans
Journal: Physiol Rev Date: 1973-07 Impact factor: 37.312

5. Studies on the toxicity of copper. II. The behaviour of microsomal membrane ATPase of the pigeon's brain tissue to copper and some other metallic substances.

Authors: R Peters; M Shorthouse; J M Walshe
Journal: Proc R Soc Lond B Biol Sci Date: 1966-12-13

Review 6. Metabolism of plasma proteins.

Authors: V Bocci
Journal: Arch Fisiol Date: 1970-07-31

7. The Kayser Fleischer ring.

Authors: J E Cairns; J M Walshe
Journal: Trans Ophthalmol Soc U K Date: 1970

8. Biliary excretion of copper in Wilson's disease.

Authors: K Gibbs; J M Walshe
Journal: Lancet Date: 1980-09-06 Impact factor: 79.321

9. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride.

Authors: J M Walshe
Journal: Lancet Date: 1982-03-20 Impact factor: 79.321

10. Observations on copper associated protein in childhood liver disease.

Authors: J Evans; S P Newman; S Sherlock
Journal: Gut Date: 1980-11 Impact factor: 23.059

7 in total

1. Predicting genotypes at loci for autosomal recessive disorders using linked genetic markers: application to Wilson's disease.

Authors: L A Farrer; B Bonne-Tamir; M Frydman; A Magazanik; K K Kidd; A M Bowcock; L L Cavalli-Sforza
Journal: Hum Genet Date: 1988-06 Impact factor: 4.132

2. The Kayser-Fleischer ring during long-term treatment in Wilson's disease (hepatolenticular degeneration). A follow-up study.

Authors: A Lössner; J Lössner; H Bachmann; J Zotter
Journal: Graefes Arch Clin Exp Ophthalmol Date: 1986 Impact factor: 3.117

3. Effective D-penicillamine treatment of an early diagnosed patient with Wilson's disease.

Authors: J P van Wouwe; M H van Weel-Sipman; M A Giesberts; D J Ruiter; H H van Gelderen
Journal: Eur J Pediatr Date: 1984-11 Impact factor: 3.183

4. Unithiol in Wilson's disease.

Authors: J M Walshe
Journal: Br Med J (Clin Res Ed) Date: 1985-03-02

5. Wilson's disease.

Authors:
Journal: Br Med J (Clin Res Ed) Date: 1984-06-02

Review 6. Mutations in humans and animals which affect copper metabolism.

Authors: J Camakaris; M Phillips; D M Danks; R Brown; T Stevenson
Journal: J Inherit Metab Dis Date: 1983 Impact factor: 4.982

7. Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease.

Authors: G Schlaug; H Hefter; B Nebeling; V Engelbrecht; P Weiss; G Stöcklin; R J Seitz
Journal: J Neurol Date: 1994-10 Impact factor: 4.849

7 in total